Suchergebnisse - "Halter, Dale"

PubPharm (9)

1

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis : Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2019

von van der Heijde, D. | Strand, V. | Tanaka, Y. | +113

2

Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

enthalten in: Rheumatology (Oxford, England) | 2015

von van der Heijde, D. | Breban, M. | Halter, D. | +9

3

Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

enthalten in: Rheumatology | 2015

von van der Heijde, D. | Breban, M. | Halter, D. | +9

4

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis : 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

enthalten in: Lancet (London, England) | 2013

von McInnes, I. | Kavanaugh, A. | Gottlieb, A. | +109

CommentIn: Lancet. 2013 Aug 31;382(9894):748-9. - PMID 23769295

5

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA) : a randomised, double-blind, controlled phase 4 trial

enthalten in: Lancet (London, England) | 2013

von Gabay, C. | Emery, P. | van Vollenhoven, R. | +85

ErratumIn: Lancet. 2013 Dec 7;382(9908):1878

6

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate : twelve-month data from a twenty-four-month phase III randomized radiographic study

enthalten in: Arthritis and rheumatism | 2013

von van der Heijde, D. | Tanaka, Y. | Fleischmann, R. | +117

7

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study) : a multicentre, randomised, double-blind, placebo-controlled, phase III trial

enthalten in: Lancet (London, England) | 2009

von Smolen, J. | Kay, J. | Doyle, M. | +93

ErratumIn: Lancet. 2009 Oct 24;374(9699):1422

8

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years : long-term results from the ATLAS trial

enthalten in: Annals of the rheumatic diseases | 2009

von van der Heijde, D. | Schiff, M. | Sieper, J. | +43

9

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis : results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)

enthalten in: The Journal of rheumatology | 2008

von Revicki, D. | Luo, M. | Wordsworth, P. | +47

ErratumIn: J Rheumatol. 2011 Apr;38(4):788

1
[1]